CLINICAL_TRIALS
trial_result
· 2020-02-20
Clinical Trial Update: An Open-Label Pharmacokinetics and Safety Study of Talazoparib [Phase 1]
Summary
Phase 1 open-label pharmacokinetics and safety study of talazoparib in patients with advanced solid tumors has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2020-02-20